Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Refametinib Phase 1 Study in Japan
jRCT2080222036Phase 1Completed
- Start
- Mar 2013
- Modality
- Small Molecules
01
Overview
Phase 1, single-arm trial of refametinib in cancer. Started Mar 2013; status: completed.
02
Drugs
refametinib
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222036.